Mykhailo Mudryk Cleared to Play Again After Suspension

Mykhailo Mudryk’s long exile from competitive football is over. After months in limbo and a four-year suspension hanging over his career, the Chelsea winger has been cleared to play again with immediate effect.

The 25-year-old has not featured since November 2024, sidelined after a failed drug test detected a low concentration of meldonium, a prohibited substance. The test dated back two years, but the consequences were brutal: a four-year ban and a cloud over one of European football’s most expensive forwards.

That cloud has now lifted — not because the test never happened, but because the landscape around it has changed.

Rule changes turn the case on its head

Mudryk appealed his suspension to the Court of Arbitration for Sport (CAS), contesting the punishment while the anti-doping world moved beneath his feet. The World Anti-Doping Agency (WADA) has since updated its procedures and scientific reporting standards. Under those new thresholds, the same sample, taken today, would not have triggered a charge at all.

The FA spelled it out in stark terms.

It confirmed that changes to the way laboratories report meldonium mean that if Mudryk’s sample “was collected today, the concentration of meldonium in the sample would not have been reported and no anti-doping rule violations would have resulted.”

That was the turning point. With WADA’s agreement, the FA and Mudryk reached a resolution to end the appeal.

There is a crucial detail, though. This is not an exoneration on paper. As part of the agreement, Mudryk accepted that he had committed the Anti-Doping Rule Violations (ADRVs) he was charged with, and agreed to a period of ineligibility equal to the time he has already served out of the game.

In other words, the ban stands in the record books, but the punishment is deemed complete. The FA’s conclusion was clear: “Mr Mudryk is no longer ineligible and may return to competition with immediate effect.”

Chelsea get their £88m winger back

For Chelsea, this is a significant moment. The club paid £88m to bring Mudryk from Shakhtar Donetsk in January 2023, a statement signing for a squad built on lavish investment and lofty expectations. Instead, they watched a prime-age winger lose a crucial stretch of his career to a case shaped as much by timing and science as by regulation.

Chelsea’s response to the resolution carried a pointed note about that context. The club welcomed the acknowledgement that advances in testing standards mean that, had “Misha’s” sample been analysed under today’s requirements, “it would not have been reported as a positive test and no anti-doping rule violation would have resulted.”

For the player, that line matters. The record will show a violation, but the club is keen to underline that modern science would never have flagged it.

The statement ended with a nod to closure: that this context “allows everyone involved to move forward.”

A career paused, not ended

Mudryk now steps back into a very different Chelsea from the one he left last November. New faces, new dynamics, and the same relentless scrutiny that has followed him since that blockbuster move from Shakhtar.

The physical challenge will be obvious after such a long competitive lay-off. The psychological one may be even greater. A four-year ban, even partially undone by procedural evolution, leaves a mark.

But the door is open again. The suspension is over. The legal fight is parked.

Chelsea, hit recently with a £10m fine and a suspended transfer ban in a separate matter, suddenly have an unexpected reinforcement already on their books: a winger once signed to change games, now simply desperate to play in one.

How quickly Mudryk can turn this from a story about anti-doping rules into one about goals, assists and performances will define the next chapter of his career.